Nine More Secondary Offerings Coming to the Market (ANAD, CERS, OFC, DCTH, ETFC, SSNC, SNTA, SLCA, VIPS)

Anadigics Inc. (NASDAQ: ANAD) filed to raise capital in a sale of common stock, but the size of the offering was not disclosed. Its market cap is only $158 million, it has seen declining sales, and it has had negative net income for two years in a row.

Cerus Corp. (NASDAQ: CERS) is worth about $233 million, and the company filed to raise capital via a stock sale. We do not yet have any details on it, but the proceeds are to help its clinical development.

Corporate Office Properties Trust (NYSE: OFC) has sold 3.9 million shares at a price of what appears to be $27.27, and that matches yesterday’s closing price. The company’s use of proceeds are to redeem its outstanding 7.625% Series J Cumulative Redeemable Preferred Shares (NYSE: OFC-PJ) and also for general corporate purposes.

Delcath Systems Inc. (NASDAQ: DCTH) is planning to sell up to $50 million in stock, which would be up to as much as one-third of its existing market value. Shares are down around $1.75, versus a $1.92 close.

E*Trade Financial Corp. (NASDAQ: ETFC) may not be a formal secondary offering, but the master puppeteer and rescuer Citadel is selling its entire 9.6% stake remaining in E*Trade. Shares were down 5% on the news, but actually this is about the best news that shareholders can get if E*Trade is thought of on a standalone basis.

SS&C Technologies Holdings Inc. (NASDAQ: SSNC) is close to a 52-week high, and its two largest shareholders are planning to sell 7.75 million shares, versus almost 79 million shares outstanding. Shares were down about 4% from the $27.74 closing price.

Synta Pharmaceuticals Corp. (NASDAQ: SNTA) has a market cap of $578 million, and it has a fresh shelf filing that would allow it to sell up to $300 million worth of stock and/or other mixed securities. This cancer and inflammatory drug developer is up about 175% from its 52-week low.

U.S. Silica Holdings Inc. (NYSE: SLCA) is selling 8.5 million shares of stock for a large shareholder at $22 per share, versus a $22.79 closing price. The presale market cap was $1.2 billion for this silica mining and processing outfit.

Vipshop Holdings Ltd. (NYSE: VIPS) has been on the books a few days for a share sale, and now we see that 7.2 million shares were sold at $24.00 per share, versus a $24.44 closing price. Some 4 million shares are for the company and 3.2 million shares are being sold by insiders.